ANXIETY DISORDERS IN PARKINSON'S DISEASE AND THEIR RELATIONSHIP WITH DEPRESSION
Keywords:
Parkinson's disease, anxiety, depressionAbstract
Anxiety disorders are among the most common psychoemotional disorders in Parkinson's disease. The level of anxiety may depend on a number of factors. The оbjective of the study was to investigate the characteristics of anxiety in Parkinson's disease. Materials and methods. The study included 120 patients with various clinical forms and stages of Parkinson's disease. The control group consisted of 30 patients of the same age without PD, but with depression. The average disease duration was 6.3±4.1 years. The Hamilton Anxiety Rating Scale (HAM-A) was used to assess anxiety, and the Hamilton Depression Rating Scale (HAM-D) was used to assess depression. Results. An analysis of psychoemotional disorders in patients with Parkinson's disease revealed that depressive syndrome is closely associated with anxiety symptoms. The level of personal anxiety was higher in patients with depression, while in patients without depression it was within the average range (p<0.05). This indicates a statistically significant relationship between depression and anxiety disorders. Conclusions. Anxiety symptoms in Parkinson's disease, combined with depression, significantly worsen the clinical condition of patients and significantly reduce their quality of life.
References
Ахмадеева Г.Н., Магжанов Р.В. Тревожно-депрессивные нарушения у пациентов с болезнью Паркинсона в Республике Башкортостан. Уральский медицинский журнал. 2015;2:44-48
Левин О.С. Диагностика и лечение депрессии при болезни Паркинсона // Атмосфера. Нервные болезни. – Москва, 2006.
– №2. – С. 2-8.
Левин О.С. Не двигательные(немоторные) проявления болезни Паркинсона: диагноз
Нодель МР. Влияние нервно-психических нарушений на качество жизни пациентов с болезнью Паркинсона. Неврологический журнал. 2015; 20(1):20–27.
44. Левин.О.С. Феноменология и лечение декомпенсации болезни Паркинсона //Неврологический журнал. – Москва,
– №1. – С. 87-112.
Халимова Х.М., Рашидова Н.С., Арипов А.Н., Матмуродов Р.Ж. Экстрапирамидал касалликларни эрта аниқлашда S100B оқсилининг ўрни ва аҳамияти// Научно-практический журнал Неврология, Тошкент,2015.-№4 (64).-С.11-14.
Barone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, Tolosa E, Weintraub D. Pramipexole for the treatment of depressive symptoms in patients with Parkinson’s disease: a randomised, double-blind, placebocontrolled trial. Lancet Neurol. 2010;9(6):573-580.
Braak H, et al. Pathology associated with sporadic Parkinson’s disease. Acta Neuropathol. 2003;106 (1):98–112.].
Chen JJ, Marsh L. Depression in Parkinson’s disease: identification and management. Pharmacotherapy. 2013;33(9):972-83.
Chendo I, Silva C, Duarte GS, et al. Frequency of Depressive Disorders in Parkinson’s Disease: A Systematic Review and Meta- Analysis. Journal of Parkinson’s Disease. 2022;12(5):1409-1418. doi:10.3233/JPD-223207
Dissanayaka NNW, Sellbach A, Matheson S, O’Sullivan JD, Silburn PA, Byrne GJ, Marsh R, Mellick GD. Anxiety disorders in Parkinson’s disease: prevalence and risk factors. Mov Disord. 2010;25:838-845.
Di Lazzaro G, Ricci M, Al-Wardat M, Schirinzi T, Scalise S, Giannini F, et al. Technology-based objective measures detect subclinical axial signs in untreated, de novo Parkinson’s disease. J Parkinsons Dis 2020;10(1). – P. 113-122.
Dissanayaka NN, White E, O’Sullivan JD, et al. The clinical spectrum of anxiety in Parkinson’s disease. Mov Disord. 2014 Jul; 29(8):967-75. doi: 10.1002 / MDS.25937.
Hemmerle AM, Herman JP, Seroogy KB. Stress, depression and Parkinson’s disease. Exp Neurol 2012;233. – P. 79–86.
Jenner P, Morris HR, Robbins TW, Goedert M, Hardy J, Ben-Shlomo Y, Bolam P, Burn D, Hindle JV, Brooks D. Parkinson’s disease – the debate on the clinical phenomenology, aetiology, pathology and pathogenesis. Journal of Parkinson’s Disease 2013;3(1). –
P. 1-11.
Oguru M, Tachibana H, Toda K, Okuda B, Oka N. Apathy and depression in Parkinson disease. J Geriatr Psych Neurology. 2010;23(1):35-41.
Skogar O, Nilsson M. Distribution of non-motor symptoms in idiopathic Parkinson’s disease and secondary parkinsonism. J Multidiscip Healthc 2018;11. – P. 525–534.
Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C. The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson’s disease. Mov Disord. 2011;26:42-80.
Shen CC, Tsai SJ, Perng CL, Kuo BI, Yang AC. Risk of Parkinson disease after depression: a nationwide population-based study. Neurology. 2013;81(17):1538-44.
Storch A, Schneider CB, Wolz M, Stürwald Y, Nebe A, Odin P, Mahler A, Fuchs G, Jost WH, Chaudhuri KR, Koch R, Reichmann H, Ebersbach G. Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology. 2013;80:800-809.
